Safety, Tolerability, and Pharmacokinetics of BGB-23339 in Healthy Japanese and Caucasian Subjects

NCT05387668 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor determined the data was no longer needed.

Conditions

Healthy Volunteers

Interventions

DRUG: BGB-23339
DRUG: Placebo

Sponsor

BeiGene